SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001739410-24-000057
Filing Date
2024-05-09
Accepted
2024-05-09 16:09:18
Documents
63
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rlyb-20240331.htm   iXBRL 10-Q 1024702
2 EX-31.1 rlyb-20240331xex311.htm EX-31.1 10284
3 EX-31.2 rlyb-20240331xex312.htm EX-31.2 10273
4 EX-32.1 rlyb-20240331xex321.htm EX-32.1 4843
5 EX-32.2 rlyb-20240331xex322.htm EX-32.2 4825
11 rlyb-20240331_g1.jpg GRAPHIC 8945
  Complete submission text file 0001739410-24-000057.txt   4636197

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rlyb-20240331.xsd EX-101.SCH 28735
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rlyb-20240331_cal.xml EX-101.CAL 42854
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rlyb-20240331_def.xml EX-101.DEF 141523
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rlyb-20240331_lab.xml EX-101.LAB 462009
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rlyb-20240331_pre.xml EX-101.PRE 322059
66 EXTRACTED XBRL INSTANCE DOCUMENT rlyb-20240331_htm.xml XML 406776
Mailing Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510
Business Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510 203- 859-3820
Rallybio Corp (Filer) CIK: 0001739410 (see all company filings)

IRS No.: 851083789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40693 | Film No.: 24930609
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)